Mode
Text Size
Log in / Sign up
N/A N=1,200 Randomized Health Services Research

Pay-it-forward Gonorrhea and Chlamydia Testing Among Men in China

Gonorrhea · Chlamydia

Enrolled (actual)
1,200
Serious AEs
0.0%
Results posted
May 2025
Primary outcome: Primary: Number of Participants Testing for Gonorrhea and Chlamydia — 390; 361; 12 Participants — p=<0.001

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Standard Pay-it-forward (Behavioral); Community Engaged Pay-it-forward (Behavioral); Control arm (Other)
Age
Adult, Older Adult · 18+ yrs
Sex
Male
Sponsor
University of North Carolina, Chapel Hill
Primary completion
Jul 2024

Outcome Measures

OutcomeResultp-value
PRIMARY
Number of Participants Testing for Gonorrhea and Chlamydia
390; 361; 12 <0.001 sig
SECONDARY
Donation Amount
225.16; 382.61 <0.001 sig
SECONDARY
Number of Participants Who Test Positive for Gonorrhea
10; 12; 1 0.0059 sig
SECONDARY
Number of Participants Who Test Positive for Chlamydia
35; 58; 0 <0.001 sig
SECONDARY
Cost Per Test Per Individual
14.10; 13.61; 20.18
SECONDARY
Mean Self Reported Gratitude Score
5.81; 6.21 <0.001 sig
SECONDARY
Mean Self Reported Community Engagement Score
0.21; 0.27; 0.32 0.007 sig
SECONDARY
Mean Community Connectedness and Cohesion Score
3.27; 3.02; 2.66 <0.001 sig
SECONDARY
Internalized Homophobia and Self-identification
3.61; 3.34; 3.44 0.727

Summary

PIONEER is a three-arm, programmatic cluster randomized controlled trial (RCT) to compare effectiveness of three implementation strategies, followed by a mixed-methods implementation evaluation study

Eligibility Criteria

Inclusion Criteria

  • at least 18 years old
  • have had sex over the past year
  • have not been tested for gonorrhea and chlamydia in the past year
  • reside in the city in the past three months
  • speak Mandarin Chinese or Cantonese
  • mentally capable of providing informed consent to test for gonorrhea and chlamydia
  • own a mobile phone

Exclusion Criteria

  • < 18 years of age
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT05723263). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search